Regenerative medicine and the neurogenic bladder

Steve J. Hodges, Anthony Atala

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Control of normal bladder function by the nervous system has been described in great detail. In some cases of injury to the spinal cord, neurogenic bladder dysfunction develops, typified by detrusor sphincter dyssynergia and decreasing bladder capacity and compliance. Numerous therapies, including anticholinergic agents, botulinum toxin, neuromodulation, and clean intermittent catheterization, have been used to maintain physiologic pressures in the neurogenic bladder. When bladder compliance falls to a dangerous level despite these treatments, enterocystoplasty has been the gold-standard therapy. Although this procedure increases bladder capacity and compliance, it has been plagued by complications, such as metabolic disorders, perforations, excessive mucous productions, and stones. Recently, the field of regenerative medicine has offered novel and improved therapies for this chronic condition. This review summarizes these recent advances.

Original languageEnglish (US)
Pages (from-to)67-74
Number of pages8
JournalCurrent Bladder Dysfunction Reports
Issue number2
StatePublished - 2008

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology


Dive into the research topics of 'Regenerative medicine and the neurogenic bladder'. Together they form a unique fingerprint.

Cite this